Radiation Business Solutions Urges Oncology Providers to Comment on Proposed Medicare Changes

NASHVILLE, Tenn., Sept. 4, 2026 /CourierPR/ -- Radiation Business Solutions (RBS), a leading advisory and management firm for oncology providers, is calling on the radiation oncology community to voice their concerns regarding proposed Medicare payment changes for 2027. The Centers for Medicare & Medicaid Services (CMS) has suggested an increase for certain treatment delivery codes, but many providers are worried about potential reductions that could affect critical services such as treatment planning, medical physics, and stereotactic treatments.

Sally Eggleston, COO of RBS, emphasized the importance of industry-wide feedback. "Radiation oncology providers are justified in their concerns about the proposed reimbursement changes," she said. "These adjustments could significantly impact patient access and the sustainability of cancer care programs."

The CMS is seeking public comments on these proposed changes by September 14, 2026. To assist providers and industry leaders in the advocacy process, RBS has created customizable resources, including sample comment letters, which can be accessed at www.RadiationBusiness.com/advocacy.

"Educating policymakers and CMS about the real-world impact of these changes is crucial," Eggleston added. "We encourage all stakeholders, including patients and advocacy groups, to share their experiences and concerns to ensure that the community's needs are properly represented."

RBS, which supports oncology providers across the United States, has a track record of providing strategic, financial, and operational expertise. In addition, the firm serves as the management organization for two nonprofit cancer care foundations, Aurora Integrated Oncology Foundation (AIOF) and Anoma Cancer Collective (ACC), which aim to preserve and expand access to community-based cancer care.